Antara Capital LP 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:45 pm Sale | 2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC | Antara Capital LP | 0 0.000% | -5,239,600 (Position Closed) | Filing |
| 2023-02-14 07:33 am Purchase | 2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC | Antara Capital LP | 5,239,600 6.400% | 5,239,600 (New Position) | Filing |